Skip to main content

2022 Rheumatology Year in Review (1-6-2023)

Dr. Jack Cush reviews the best of 2022 in Rheumatology - highlights on new drug indications, breakthrough lupus therapies, new biosimilars and the multivitamin letdown.

2022 Match - Strong Appeal of Adult Rheumatology, Less So in Pediatric Rheumatology The ACR is pleased to announce ano

Social Author Name
Dr. John Cush
Tweet Content
2022 Match - Strong Appeal of Adult Rheumatology, Less So in Pediatric Rheumatology The ACR is pleased to announce another successful recruitment season and welcomes this impressive pool of applicants to the field of rheumatology. https://t.co/XEQCq5Pnnt https://t.co/quvxT9njI4

Extreme Global Costs of Physical Inactivity A global, population-based study shows that physical inactivity is not onl

Social Author Name
Dr. John Cush
Tweet Content
Extreme Global Costs of Physical Inactivity A global, population-based study shows that physical inactivity is not only an important modifiable risk factor for NCDs and mental health conditions, it also imparts a considerable health and economic burden. https… https://t.co/eZEW6LGpiL

Should Kids w/ MIS-C get the COVID vaccine? Yes - study of 385 pt > 5 yrs w/ Hx of multisystem inflammatory syndrome

Social Author Name
Dr. John Cush
Tweet Content
Should Kids w/ MIS-C get the COVID vaccine? Yes - study of 385 pt > 5 yrs w/ Hx of multisystem inflammatory syndrome showed no serious adverse events after COVID-19 vaccination. The safety profile of COVID-19 vax is same as gen population https://t.co/dr2QBQsMhE? https://t.co/WbsUuYEsez

SLE - New Drug Development

ADD THE FIRST COMMENT

The Dartmouth Hitchcock Medical Center (DHMC) is searching for a new Chief of the Section of Rheumatology - one who is d

Social Author Name
Dr. John Cush
Tweet Content
The Dartmouth Hitchcock Medical Center (DHMC) is searching for a new Chief of the Section of Rheumatology - one who is dynamic, experienced, future-oriented academic Rheumatologist https://t.co/TD6gjWAzZu https://t.co/p4NSe6VtKD
2022 Rheumatology Year in Review

2022 was a year of recovery, discovery, and some losses.  While still dealing with the aftermath of COVID-19, rheumatologists were resilient as leaders for their patients and research in advancing rheumatologic care.

Subscribe to
×